Bausch Health Companies Inc (NYSE:BHC)
$ 6.88 -0.07 (-1.01%) Market Cap: 2.52 Bil Enterprise Value: 23.88 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 73/100

Bausch Health Companies Inc at Barclays High Yield Bond & Syndicated Loan Conference Transcript

May 24, 2022 / 04:00PM GMT
Release Date Price: $9.28 (-5.21%)
Sean Palmer

Great. Thanks, everyone, for joining. For those who don't know me, Sean Palmer from Barclays, subbing in for Rishi today. To my left, I have Tom Vadaketh, CFO of Bausch Health, and Will Woodfield, Director of Bausch Health. Thanks, everyone, for joining in the room today. Thanks, Tom and Will for joining. Really appreciate it. Maybe start to give you a few minutes to give your background for those don't know you yet as well as any perspective on, obviously, the last few weeks of activity.

Thomas G. Vadaketh
Bausch Health Companies Inc. - Executive VP & CFO

Yes. Thank you, Sean. And maybe I'll just kick off with just thanking Barclays, you, yourself, Sean; Rishi, who is somewhere in the audience, but Barclays has been a huge supporter of the company the last few years, and we all appreciate it. I've been in the company since January. The Bausch + Lomb part of the business was IPO-ed on the 10th of May. And I took over officially as the CFO for Bausch Health at that point, so from the 10th of May. So going about a couple of weeks, but I've been here

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot